Clinical trial

Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study

NCT02092961

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE2

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2014-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

FostamatinibDRUG · verified · RxNorm: fostamatinib

AdalimumabDRUG · verified · RxNorm: adalimumab

Placebo of FostamatinibDRUG

Placebo of AdalimumabDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

PhoenixArizona, United States1 AustinTexas, United States1 WarsawPoland1 BudapestHungary1 HamburgGermany1 PragueCzechia1 ManchesterUnited Kingdom1 AmsterdamNetherlands1 BrooklynNew York, United States1 YaroslavlRussia1 PretoriaSouth Africa1 PlevenBulgaria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02092961 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.